The effects of vandetanib on paclitaxel tumor distribution and antitumor activity in a xenograft model of human ovarian carcinoma.

The effects of vandetanib on paclitaxel tumor distribution and antitumor activity in a xenograft model of human ovarian carcinoma.

This study was designed to determine the effects of vandetanib, a small-molecule receptor tyrosine kinase inhibitor of vascular endothelial growth factor and epidermal growth factor receptor, on paclitaxel (PTX) tumor distribution and antitumor activity in xenograft models of human ovarian carcinoma...

Detaylı Bibliyografya
Asıl Yazarlar:	Cesca, M, Frapolli, R, Berndt, A, Scarlato, V, Richter, P, Kosmehl, H, D'Incalci, M, Ryan, A, Giavazzi, R
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2009

Benzer Materyaller

The Effects of Vandetanib on Paclitaxel Tumor Distribution and Antitumor Activity in a Xenograft Model of Human Ovarian Carcinoma
Yazar:: Marta Cesca, ve diğerleri
Baskı/Yayın Bilgisi: (2009-11-01)

Hyaluronic Acid- Paclitaxel: Antitumor Efficacy against CD44(+) Human Ovarian Carcinoma Xenografts
Yazar:: Edmond Auzenne, ve diğerleri
Baskı/Yayın Bilgisi: (2007-06-01)

Combination of vandetanib, radiotherapy, and irinotecan in the LoVo human colorectal cancer xenograft model.
Yazar:: Wachsberger, P, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Determination of paclitaxel distribution in solid tumors by nano-particle assisted laser desorption ionization mass spectrometry imaging.
Yazar:: Lavinia Morosi, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

Vandetanib inhibits growth of adenoid cystic carcinoma in an orthotopic nude mouse model.
Yazar:: Choi, S, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Preclinical Activity of Two Paclitaxel Nanoparticle Formulations After Intraperitoneal Administration in Ovarian Cancer Murine Xenografts
Yazar:: Demuytere J, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Modulation of gene expression associated with copy number variation identifies key regulatory programs in high-grade serous ovarian carcinoma
Yazar:: Martina Vescio, ve diğerleri
Baskı/Yayın Bilgisi: (2023-07-01)

Metronomic S-1 Chemotherapy and Vandetanib: An Efficacious and Nontoxic Treatment for Hepatocellular Carcinoma
Yazar:: Hideki Iwamoto, ve diğerleri
Baskı/Yayın Bilgisi: (2011-03-01)

The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats.
Yazar:: Cervellini, I, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Assessment of acute antivascular effects of vandetanib with high-resolution dynamic contrast-enhanced computed tomographic imaging in a human colon tumor xenograft model in the nude rat.
Yazar:: Tai, J, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Assessment of acute antivascular effects of vandetanib with high-resolution dynamic contrast-enhanced computed tomographic imaging in a human colon tumor xenograft model in the nude rat
Yazar:: Tai, J, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Vandetanib for the Treatment of Metastatic Medullary Thyroid Cancer
Yazar:: Nils Degrauwe, ve diğerleri
Baskı/Yayın Bilgisi: (2012-06-01)

Biodistribution and pharmacokinetics of a telodendrimer micellar paclitaxel nanoformulation in a mouse xenograft model of ovarian cancer
Yazar:: Xiao W, ve diğerleri
Baskı/Yayın Bilgisi: (2012-03-01)

Selective use of vandetanib in the treatment of thyroid cancer
Yazar:: Fallahi P, ve diğerleri
Baskı/Yayın Bilgisi: (2015-07-01)

PEGylated recombinant human hyaluronidase (PEGPH20) pre-treatment improves intra-tumour distribution and efficacy of paclitaxel in preclinical models
Yazar:: Lavinia Morosi, ve diğerleri
Baskı/Yayın Bilgisi: (2021-09-01)

Assessment of Acute Antivascular Effects of Vandetanib with High-Resolution Dynamic Contrast-Enhanced Computed Tomographic Imaging in a Human Colon Tumor Xenograft Model in the Nude Rat
Yazar:: Joo Ho Tai, ve diğerleri
Baskı/Yayın Bilgisi: (2010-09-01)

Biophysical and computational characterization of vandetanib–lysozyme interaction
Yazar:: Kabir, Md Zahirul, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Investigating the effect of vandetanib and celecoxib combination on angiogenesis
Yazar:: Abdul Qadir, MPhil, ve diğerleri
Baskı/Yayın Bilgisi: (2023-10-01)

Dermoscopic findings of perifollicular pigmentation associated with vandetanib
Yazar:: Jade Cury-Martins, ve diğerleri
Baskı/Yayın Bilgisi: (2018-10-01)

Onvansertib and paclitaxel combined in platinum-resistant ovarian carcinomas
Yazar:: Roberta Affatato, ve diğerleri
Baskı/Yayın Bilgisi: (2022-05-01)

A novel compound ARN-3236 inhibits salt-inducible kinase 2 and sensitizes ovarian cancer cell lines and xenografts to paclitaxel.
Yazar:: Zhou, J, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Effects of vandetanib on adenoma formation in a dextran sodium sulphate enhanced Apc(MIN/+) mouse model.
Yazar:: Alferez, D, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Combination of paclitaxel, bevacizumab and MEK162 in second line treatment in platinum-relapsing patient derived ovarian cancer xenografts
Yazar:: Francesca Ricci, ve diğerleri
Baskı/Yayın Bilgisi: (2017-05-01)

Baseline VEGF as a potential predictive biomarker of vandetanib clinical benefit in patients with advanced NSCLC
Yazar:: Heymach, J, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Impact of tumor cell VEGF expression on the in vivo efficacy of vandetanib (ZACTIMA; ZD6474).
Yazar:: Siemann, D, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Inhibitory effect of luteolin on the metabolism of vandetanib in vivo and in vitro
Yazar:: Yuxin Shen, ve diğerleri
Baskı/Yayın Bilgisi: (2025-03-01)

Vandetanib (ZD6474) in the Treatment of Medullary Thyroid Cancer
Yazar:: Hari Deshpande, ve diğerleri
Baskı/Yayın Bilgisi: (2011-01-01)

Clusterin Interacts with Paclitaxel and Confer Paclitaxel Resistance in Ovarian Cancer
Yazar:: Dong Choon Park, ve diğerleri
Baskı/Yayın Bilgisi: (2008-09-01)

Effect of Vandetanib Treatment on Cystic Changes in the Liver following Metastasis from Medullary Thyroid Carcinoma
Yazar:: Ai Matsui, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

Establishment and characterization of ovarian clear cell carcinoma patient-derived xenografts
Yazar:: Joseph J. Caumanns, ve diğerleri
Baskı/Yayın Bilgisi: (2025-02-01)

Driving p53 Response to Bax Activation Greatly Enhances Sensitivity to Taxol by Inducing Massive Apoptosis
Yazar:: Paola De Feudis, ve diğerleri
Baskı/Yayın Bilgisi: (2000-05-01)

Nitric oxide synthase inhibition enhances the antitumor effect of radiation in the treatment of squamous carcinoma xenografts.
Yazar:: Robert J G Cardnell, ve diğerleri
Baskı/Yayın Bilgisi: (2011-01-01)

Evaluating vandetanib in the treatment of medullary thyroid cancer: patient-reported outcomes
Yazar:: Fallahi P, ve diğerleri
Baskı/Yayın Bilgisi: (2019-08-01)

N-Acetylcysteine Augments Surface Thiols and Differentially Modulates Cell Adhesion and Invasion in vitro and Metastatic Potential in vivo of B16F1 Melanoma
Yazar:: T. Laragione, ve diğerleri
Baskı/Yayın Bilgisi: (2005-01-01)

Vandetanib induced phototoxic reaction progressed to toxic epidermal necrolysis
Yazar:: Busra Demirbag Gul, ve diğerleri
Baskı/Yayın Bilgisi: (2022-02-01)

LAMININ-5. A POTENTIAL TOOL IN DIAGNOSIS OF HEAD AND NECK SQUAMOUS CELL CARCINOMA
Yazar:: Hartwig Kosmehl, ve diğerleri
Baskı/Yayın Bilgisi: (2002-12-01)

Antitumor action of an aminochromene derivative on human - derived lung adenocarcinoma xenograft model
Yazar:: E. A. Samishina, ve diğerleri
Baskı/Yayın Bilgisi: (2019-06-01)

Transportan in nanocarriers improves skin localization and antitumor activity of paclitaxel
Yazar:: Pepe D, ve diğerleri
Baskı/Yayın Bilgisi: (2016-05-01)

Treatment of Metastatic Medullary Thyroid Cancer With Vandetanib: Need to Stratify Patients on Basis of Calcitonin Doubling Time Reply
Yazar:: Jr, W, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Trabectedin and Plitidepsin: Drugs from the Sea that Strike the Tumor Microenvironment
Yazar:: Carlos M. Galmarini, ve diğerleri
Baskı/Yayın Bilgisi: (2014-01-01)